| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
AbCellera Biologics Inc (NASDAQ: ABCL)
ABCL Technical Analysis
5
| As on 9th Jun 2023 ABCL STOCK Price closed @ 7.09 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 10.23 & Strong Sell for SHORT-TERM with Stoploss of 10.46 we also expect STOCK to react on Following IMPORTANT LEVELS. |
ABCLSTOCK Price
| Open | 7.19 | Change | Price | % |
| High | 7.23 | 1 Day | -0.07 | -0.98 |
| Low | 6.99 | 1 Week | 0.12 | 1.72 |
| Close | 7.09 | 1 Month | 0.45 | 6.78 |
| Volume | 2601757 | 1 Year | -8.65 | -54.96 |
| 52 Week High 15.74 | 52 Week Low 5.66 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| ABCL Daily Charts |
ABCL Intraday Charts |
Whats New @ Bazaartrend |
ABCL Free Analysis |
|
|
ABCL Important Levels Intraday
| RESISTANCE | 7.55 |
| RESISTANCE | 7.40 |
| RESISTANCE | 7.31 |
| RESISTANCE | 7.22 |
| SUPPORT | 6.96 |
| SUPPORT | 6.87 |
| SUPPORT | 6.78 |
| SUPPORT | 6.63 |
ABCL Forecast May 2024
| 4th UP Forecast | 17.05 |
| 3rd UP Forecast | 13.86 |
| 2nd UP Forecast | 11.88 |
| 1st UP Forecast | 9.91 |
| 1st DOWN Forecast | 4.27 |
| 2nd DOWN Forecast | 2.3 |
| 3rd DOWN Forecast | 0.32 |
| 4th DOWN Forecast | -2.87 |
ABCL Weekly Forecast
| 4th UP Forecast | 12.12 |
| 3rd UP Forecast | 10.51 |
| 2nd UP Forecast | 9.51 |
| 1st UP Forecast | 8.51 |
| 1st DOWN Forecast | 5.67 |
| 2nd DOWN Forecast | 4.67 |
| 3rd DOWN Forecast | 3.67 |
| 4th DOWN Forecast | 2.06 |
ABCL Forecast2024
| 4th UP Forecast | 27.28 |
| 3rd UP Forecast | 20.81 |
| 2nd UP Forecast | 16.8 |
| 1st UP Forecast | 12.8 |
| 1st DOWN Forecast | 1.38 |
| 2nd DOWN Forecast | -2.62 |
| 3rd DOWN Forecast | -6.63 |
| 4th DOWN Forecast | -13.1 |
AbCellera Biologics Inc ( NASDAQ USA Symbol : ABCL )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
ABCL Business Profile
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, AI-powered drug discovery platform searches and analyzes the database of natural immune systems to find antibodies that can be developed as drugs. As of December 31, 2020, the company had 103 discovery programs that are either completed, in progress, or under contract. It has a discovery partnership agreement with Eli Lilly and Company. AbCellera Biologics Inc. was founded in 2012 and is headquartered in Vancouver, Canada. Address: 2215 Yukon Street, Vancouver, BC, Canada, V5Y 0A1
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service